CervoMed (CRVO) Treasury Shares (2015 - 2023)
CervoMed (CRVO) posted Treasury Shares of $2.0 million for Q2 2023, up 67274.57% sequentially from $2910.0 in Q1 2023, and little changed YoY from $2.0 million in Q2 2022.
CervoMed (CRVO) Treasury Shares (2015 - 2023) Analysis & Trends
CervoMed has reported Treasury Shares for 8 years, with the latest figure at $2.0 million in Q2 2023.
- Quarterly Treasury Shares changed 0.0% year-over-year to $2.0 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $2.0 million (changed 0.0% YoY) and the FY2022 annual result came in at $2.0 million, up 89.45% from the prior year.
- Treasury Shares grew to $2.0 million in Q2 2023 per CRVO's latest filing, from $2910.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $2.0 million in Q2 2022 and troughed at $2910.0 in Q1 2023.
- A 4-year average of $917442.3 and a median of $1.0 million in 2021 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2021 and 2023: Treasury Shares soared 18685.44% in 2021, then tumbled 43.84% in 2023.
- Over 4 years, Treasury Shares stood at $5509.0 in 2020, then jumped by 18685.44% to $1.0 million in 2021, then jumped by 89.45% to $2.0 million in 2022, then changed by 0.0% to $2.0 million in 2023.
- According to Business Quant data, Treasury Shares over the past three periods registered $2.0 million, $2910.0, and $2.0 million for Q2 2023, Q1 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.96 Mn |
| Jun 30, 2023 | 1.96 Mn |
| Mar 31, 2023 | 2,910.00 |
| Mar 31, 2023 | 2,910.00 |
| Dec 31, 2022 | 1.96 Mn |
| Dec 31, 2022 | 1.96 Mn |
| Sep 30, 2022 | 1.03 Mn |
| Sep 30, 2022 | 1.03 Mn |
| Jun 30, 2022 | 1.96 Mn |
| Jun 30, 2022 | 1.96 Mn |
| Mar 31, 2022 | 5,182.00 |
| Mar 31, 2022 | 5,182.00 |
| Dec 31, 2021 | 1.03 Mn |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | 291,800.00 |
| Sep 30, 2021 | 291,800.00 |
| Dec 31, 2020 | 5,509.00 |
| Dec 31, 2020 | 5,509.00 |
| Mar 31, 2018 | 1,533.00 |
| Mar 31, 2018 | 1,533.00 |